Regulation 293 Prohibition of supply to the public for promotional purposes
United Kingdom
The holder of F2either a temporary authorisation or—
in the case of a medicinal product for sale or supply in Great Britain, a UKMA(GB), UKMA(UK), COR(GB), COR(UK), THR(GB) or THR(UK); or
in the case of a medicinal product for sale or supply in Northern Ireland, a UKMA(NI), UKMA(UK), COR(NI), COR(UK), THR(NI), THR(UK) F3... or Article 126a authorisation,
may not sell or supply a medicinal product for a promotional purpose to a person who is not qualified to prescribe medicinal products.
A person who carries on a medicines business may not sell or supply a medicinal product for a promotional purpose to a person who is not qualified to prescribe medicinal products.
This regulation applies regardless of whether the promotional purpose is that of the seller or supplier or of a third party.
In this regulation “medicines business” means a business that consists in whole or in part of manufacturing, selling or supplying medicinal products.
Annotations
Textual amendments
- F1
Reg. 293(1) substituted (31.12.2020) by S.I. 2019/775, reg. 214 (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 171)
- F2
Words in reg. 293(1) inserted (31.12.2020 immediately after S.I. 2019/775 comes into force) by The Human Medicines (Coronavirus) (Further Amendments) Regulations 2020 (S.I. 2020/1594), regs. 1(3), 13 and The Human Medicines (Coronavirus) (Further Amendments) Regulations 2020 (S.R. 2020/350), regs. 1(3), 13
- F3
Words in reg. 293(1)(b) omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 124